Target intelligence / Profile preview

Ras homolog enriched in brain-like protein 1 (RHEBL1)

Target
RHEBL1
Molecular classification
Small GTPase, Ras superfamily, Enzyme
01

Overview

Ras homolog enriched in brain-like protein 1 (RHEBL1) is a member of the Ras superfamily of small GTPases and shares high sequence similarity with Rheb (Ras homolog enriched in brain)[3]. Like Rheb, RHEBL1 contains a C-terminal CaaX motif required for farnesylation and association with cell membranes. RHEBL1 is capable of activating the mTORC1 (mechanistic target of rapamycin complex 1) signaling pathway, stimulating cell growth and proliferation, particularly evident in overexpression systems. In cells lacking Rheb, RHEBL1 can compensate and restore mTORC1 signaling, indicating functional redundancy[3]. The protein cycles between inactive GDP-bound and active GTP-bound states, with GTP-bound RHEBL1 promoting mTORC1 activation. Increased activity or overexpression of RHEBL1 may play roles in diseases associated with dysregulated cell growth, such as cancer; however, it has not been characterized as a direct drug target, and little is known about specific drug interactions or therapeutic safety concerns. RHEBL1 occupies a niche as a signaling node in cellular growth regulation via the mTOR pathway[1][2][3].

Other names
Rheb-like protein 1RHEBL1RhebL1cRHEB2Ras homolog enriched in brain like-1 cRas homolog enriched in brain-like protein 1Rheb2MGC34869FLJ25797
02

Biological functions

Signal transductionmTORC1 activationCell growthCell proliferation
03

Disease associations

CancerTuberous sclerosisOther diseases related to uncontrolled cell growth

Beyond the preview

Go deeper on Ras homolog enriched in brain-like protein 1 (RHEBL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ras homolog enriched in brain-like protein 1 (RHEBL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call